Komori
Medipal Holdings (7459) · RiskRestated

Logistics and Information Systems Investment Costs and Declining Selling Prices Associated with Intensified Competition

First written in FY2016. 14 of 15 entries say "Restated". Latest entry: FY2022.

15entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20222016: 320162017: 220172018: 420182019: 220192020: 220202021: 120212022: 12022
Same theme, other companies

The whole theme swung hardest in 2026: 21 of 39 companies on the "Worse" side.

39 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 72 companies compared. The sentences above are computed from all 72.
Full recordFilings, disclosures and news, newest first
  1. FY2022RestatedAnnual report

    「In the cosmetics and daily necessities and over-the-counter pharmaceutical wholesale industries, which comprise our group's principal businesses, competition across industry sectors and business formats continues to intensify, while companies continue to expand their scale through M&A.」

    The risk of changes in transaction terms resulting from intensifying competition across industry sectors and business formats and restructuring among business partners continues.
  2. FY2021RestatedAnnual report

    「However, if the policies or transaction terms of business partners change substantially in the future as a result of further intensification of competition or corporate restructuring among business partners, this may affect performance and financial condition.」

    The risk of changes in transaction terms associated with intensifying competition and corporate restructuring among business partners continues.
  3. FY2021-Q2RestatedAnnual report

    「During the first six months of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the risks of increased logistics and information systems investment costs and lower selling prices associated with intensifying competition.
  4. FY2020-Q3RestatedAnnual report

    「No new business or other risks arose during the cumulative third quarter under review. In addition, there have been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the risks of the logistics and information systems investment burden and lower selling prices associated with responding to competition.
  5. FY2020-Q2RestatedAnnual report

    「During the first six months of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the risks of the logistics and information systems investment burden and lower selling prices associated with responding to competition.
  6. FY2019-Q3RestatedAnnual report

    「No new business or other risks arose during the cumulative third quarter under review. In addition, there have been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the risks of the logistics and information systems investment burden and lower selling prices associated with responding to competition.
  7. FY2019-Q2RestatedAnnual report

    「During the first six months of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the risks of the logistics and information systems investment burden and lower selling prices associated with responding to competition.
  8. FY2019-Q1RestatedAnnual report

    「During the first quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the risks of the logistics and information systems investment burden and lower selling prices associated with responding to competition.
  9. FY2018RestatedAnnual report

    「Increased investment costs associated with enhancing and expanding logistics and information systems functions, or selling prices falling more than expected, may affect performance.」

    The risks of the logistics and information systems investment burden associated with responding to competition and lower selling prices continue.
  10. FY2018-Q3RestatedAnnual report

    「No new business or other risks arose during the cumulative third quarter under review. In addition, there have been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the risks of increased logistics and information systems investment costs and lower selling prices associated with intensifying competition.
  11. FY2018-Q2RestatedAnnual report

    「During the first six months of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the risks of increased logistics and information systems investment costs and lower selling prices associated with intensifying competition.
  12. FY2017-Q3RestatedAnnual report

    「No new business or other risks arose during the cumulative third quarter under review. In addition, there have been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the risks of increased investment costs and lower selling prices associated with intensifying competition.
  13. FY2017-Q2RestatedAnnual report

    「During the first six months of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the risks of increased investment costs and lower selling prices associated with intensifying competition.
  14. FY2017-Q1RestatedAnnual report

    「During the first quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the risks of increased investment costs and lower selling prices associated with intensifying competition.
  15. FY2016First statedAnnual report

    「The scale and scope of competitors are expanding. To respond, increased investment costs associated with enhancing and expanding logistics and information systems functions, as well as selling prices falling more than expected, may affect performance.」

    The company identifies both the investment burden of responding to competition and the risk of selling prices falling more than expected.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Medipal Holdings's next results are scheduled for 2026-11-05. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Logistics and Information Systems Investment Costs and Declining Selling Prices Associated with Intensified Competition | MEDIPAL HOLDINGS CORPORATION (7459) | Komori